🔎 Trials Near Me

Utama › Aterosklerosis › Texas › Houston

Kajian klinikal Aterosklerosis di Houston, TX

10 kajian untuk Aterosklerosis sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Mengambil pesertaFasa 2
  • Cardiovascular Specialists of Willowbrook, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07783802

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Mengambil pesertaFasa 2
  • East Texas Cardiology PA, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07448038

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Mengambil pesertaFasa 3
  • Center for Cardiometabolic Disease Prevention/Baylor College of Medicine, Houston
  • Orion Medical - Houston, Houston
  • Research Physicians Network, LLC, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Mengambil pesertaFasa 3
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • dan 2 lagi
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Mengambil pesertaFasa 2/3
  • Clinical Research Strategies, Houston
  • DaVita Clinical Research, Houston
  • Aqua Research Institute, Houston
  • dan 4 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Mengambil pesertaFasa 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
  • dan 4 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Mengambil pesertaFasa 3
  • Kelsey Seybold Research Foundation, Houston
Umur 18 hingga 80 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06813911

Pelacarsen Roll-over Extension Program

Mengambil pesertaFasa 3
  • Angiocardiac Care of Texas PA, Houston
  • Dallas Heart and Vascular Consultants PA, Houston
  • Dallas Heart and Vascular Consultants PA, Houston
Umur 18 hingga 100 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06875973

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Mengambil pesertaFasa 4
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Dis 2025 · NCT02915198

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Mengambil pesertaFasa 2
  • UT Health Houston, Houston
Umur 40 ke atas · Semua jantina · Dikemas kini 17 Dis 2025 · NCT05488431

Kajian Aterosklerosis di bandar lain

Kajian lain di Houston

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.